Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Progress in retinal and eye research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.preteyeres.2009.10.001PMID 19854291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY WITH PHOTODYNAMIC THERAPY

  2012cited by this paper
• DIGITAL INDOCYANINE GREEN VIDEOANGIOGRAPHY AND CHOROIDAL NEOVASCULARIZATION

  2012cited by this paper
• One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.

  2010cited by this paper
• Haemorrhagic pigment epithelial detachment as a predictive feature of polypoidal choroidal vasculopathy in a Chinese population

  2010cited by this paper
• Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy.

  2009cited by this paper
• Comparative Assessment of Photodynamic Therapy for Typical Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A Multicenter Study in Hyogo Prefecture, Japan

  2009cited by this paper
• ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy.

  2009cited by this paper
• A CLASSIFICATION SYSTEM FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

  2009cited by this paper
• SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

  2009cited by this paper
• Age-related maculopathy - linking aetiology and pathophysiological changes to the ischaemia hypothesis.

  2009cited by this paper
• Argon laser photocoagulation for the treatment of polypoidal choroidal vasculopathy

  2009cited by this paper
• Age-related macular degeneration.

  2008cited by this paper
• The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis.

  2008cited by this paper
• Genetics of Intracranial Aneurysms

  2008cited by this paper
• Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age‐related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population

  2008cited by this paper
• Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy

  2008cited by this paper
• The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy

  2008cited by this paper
• Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy.

  2008cited by this paper
• Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA

  2008cited by this paper
• Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy.

  2008cited by this paper
• Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients

  2008cited by this paper
• Clinicopathologic findings in polypoidal choroidal vasculopathy.

  2008cited by this paper
• Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

  2008cited by this paper
• Polypoidal choroidal vasculopathy and treatments

  2008cited by this paper
• Role of Photodynamic Therapy in Polypoidal Choroidal Vasculopathy

  2007cited by this paper
• Clinical update: new treatments for age-related macular degeneration.

  2007cited by this paper
• Clinical characteristics of exudative age-related macular degeneration in Japanese patients.

  2007cited by this paper
• TOMOGRAPHIC FEATURES OF BRANCHING VASCULAR NETWORKS IN POLYPOIDAL CHOROIDAL VASCULOPATHY

  2007cited by this paper
• Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.

  2007cited by this paper
• Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography

  2007cited by this paper
• Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography

  2007cited by this paper
• Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration.

  2007cited by this paper
• Subtype lesions of neovascular age-related macular degeneration in Chinese patients

  2007cited by this paper
• LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population.

  2007cited by this paper
• Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration

  2007cited by this paper
• Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy

  2007cited by this paper
• Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography

  2007cited by this paper
• A haplotype spanning two genes, ELN and LIMK1, decreases their transcripts and confers susceptibility to intracranial aneurysms.

  2006cited by this paper
• Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.

  2006cited by this paper
• The Role of Human HtrA1 in Arthritic Disease*

  2006cited by this paper
• Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

  2006cited by this paper
• Fotocoagulación láser en la vasculopatía coroidal polipoidea idiopática: Seguimiento superior a un año

  2005cited by this paper
• Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin

  2005cited by this paper
• Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm.

  2005cited by this paper
• Complement Factor H Polymorphism in Age-Related Macular Degeneration

  2005cited by this paper
• A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

  2005cited by this paper
• Complement Factor H Polymorphism and Age-Related Macular Degeneration

  2005cited by this paper
• Retinal neovascularisation arising from hyalinised blood vessels

  2005cited by this paper
• Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration

  2005cited by this paper
• Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation

  2005cited by this paper
• The origins of polypoidal choroidal vasculopathy

  2005cited by this paper
• 28 000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking

  2005cited by this paper
• Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population

  2004cited by this paper
• Photodynamic Therapy with Verteporfin for Polypoidal Choroidal Vasculopathy of the Macula

  2004cited by this paper
• The human complement factor H: functional roles, genetic variations and disease associations.

  2004cited by this paper
• Polypoidal choroidal vasculopathy in elderly Chinese patients

  2004cited by this paper
• Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy.

  2004cited by this paper
• Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy

  2004cited by this paper
• HtrA1 serine protease inhibits signaling mediated by Tgfβ family proteins

  2004cited by this paper
• Pathological features of surgically excised polypoidal choroidal vasculopathy membranes

  2004cited by this paper
• Apolipoprotein E polymorphisms in Japanese patients with polypoidal choroidal vasculopathy and exudative age-related macular degeneration.

  2004cited by this paper
• Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

  2004cited by this paper
• Polypoidal choroidal vasculopathy.

  2004cited by this paper
• Prevalence of age-related macular degeneration in the United States.

  2004cited by this paper
• Systematic identification and analysis of exonic splicing silencers.

  2004cited by this paper
• A study of laser photocoagulation for polypoidal choroidal vasculopathy.

  2003cited by this paper
• Risk factors for age related maculopathy in a Japanese population: the Hisayama study

  2003cited by this paper
• Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics.

  2003cited by this paper
• The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study.

  2003cited by this paper
• Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials¿TAP Report No. 5

  2002cited by this paper
• Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

  2002cited by this paper
• Polypoidal choroidal vasculopathy: natural history.

  2002cited by this paper
• TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY WITH PHOTODYNAMIC THERAPY

  2002cited by this paper
• Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.

  2002cited by this paper
• Polypoidal choroidal vasculopathy with large vascular network

  2002cited by this paper
• Polypoidal choroidal vasculopathy.

  2002cited by this paper
• Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation

  2002cited by this paper
• A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

  2001cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

  2001cited by this paper
• Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11.

  2001cited by this paper
• POLYPOIDAL CHOROIDAL VASCULOPATHY IN ITALY

  2001cited by this paper
• The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration.

  2000cited by this paper
• Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments

  2000cited by this paper
• TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.

  2000cited by this paper
• Polypoidal choroidal vasculopathy in Caucasians

  2000cited by this paper
• Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy.

  2000cited by this paper
• Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration.

  1999cited by this paper
• Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

  1999cited by this paper
• Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

  1999cited by this paper
• Idiopathic polypoidal choroidal vasculopathy in Japanese patients.

  1999cited by this paper
• Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy.

  1999cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

  1999cited by this paper
• Idiopathic polypoidal choroidal vasculopathy: a peripheral lesion.

  1998cited by this paper
• DIODE LASER PHOTOCOAGULATION IN IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY

  1998cited by this paper
• Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography.

  1998cited by this paper
• Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age.

  1998cited by this paper
• Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study.

  1998cited by this paper
• Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of theCBP/p300 coactivator by the hypoxia‐induciblefactor‐1α

  1998cited by this paper
• Idiopathic polypoidal choroidal vasculopathy of the macula.

  1998cited by this paper
• Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

  1998cited by this paper

• Prevalence of Polypoidal Choroidal Vasculopathy Beyond Recalcitrant Macular Neovasculopathies in a European AMD Cohort and Therapeutic Response to Brolucizumab.

  2026cites this paper
• Intravitreal aflibercept 8 mg versus 2 mg in Asian patients with neovascular age-related macular degeneration: 48-week analysis of the Phase 3 PULSAR trial.

  2026cites this paper
• Three-year outcomes of polypoidal choroidal vasculopathy according to polypoidal regression on optical coherence tomography angiography

  2025cites this paper
• Polypoidal Choroidal Vasculopathy: From Clinicopathological and Molecular Perspectives

  2025cites this paper
• Combining Hypo-Reflective Structural En Face Imaging Improves Polypoidal Lesion Detection on Spectral-Domain OCT Angiography

  2025cites this paper
• Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis

  2025cites this paper
• Efficacy of Intravitreal Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration Patients with or without Polypoidal Choroidal Vasculopathy: A Meta-Analysis.

  2025cites this paper
• Massive Hemorrhage in PCV Is Associated With Lower‐Than‐Normal VEGF Level and Dramatically Elevated Inflammatory Cytokine Levels in Aqueous Mingxuan

  2025cites this paper
• POLYPOIDAL CHOROIDAL VASCULOPATHY MANIFESTATION IN EXTRA-AXIAL CAVERNOUS TUMOR: A RARE FINDINGS IN CHRONIC PAPILLEDEMA

  2025cites this paper
• Consensus and Guidelines on Diagnosis and Management of Polypoidal Choroidal Vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS).

  2025cites this paper
• The CFH–CFHR5 Locus in Wet Age-Related Macular Degeneration, Polypoidal Choroidal Vasculopathy, and Central Serous Chorioretinopathy

  2025cites this paper
• Macular neovascularization.

  2024cites this paper
• Real world treatment outcomes in polypoidal choroidal vasculopathy in a Caucasian population of British ethnicity

  2024cites this paper
• Analyzing shifts in age-related macular degeneration research trends since 2014: A bibliometric study with triple-map Sankey diagrams (TMSD)

  2024cites this paper
• A study of the relationship between cytokine levels and the response to anti-VEGF therapy in polypoid choroidal vasculopathy with different choroidal thicknesses

  2024cites this paper
• Drusen in AMD from the Perspective of Cholesterol Metabolism and Hypoxic Response

  2024influential citation
• Optical Coherence Tomography Characteristics for Differentiating Scars in Type 1 (Polypoidal Choroidal Vasculopathy (PCV)) and Type 2 (Classical) Macular Neovascularization (MNV) in Age-Related Macular Degeneration (AMD)

  2024cites this paper
• Comparison of One-Year Outcome of Intravitreal Aflibercept with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

  2024cites this paper
• Identification of Genetic Variants for Risk Prediction and Early Diagnosis of Age-Related Macular Degeneration in the Taiwanese Population

  2024cites this paper
• Polypoidal choroidal vasculopathy versus neovascular age related macular degeneration: A comparison of demographics, clinical presentation, and treatment outcomes in Nigerians

  2024cites this paper
• INCIDENCE AND PROGRESSION OF AGE-RELATED MACULAR DEGENERATION AMONG PATIENTS WITH AND WITHOUT OBSTRUCTIVE SLEEP APNEA

  2024cites this paper
• Aqueous microRNA profiling in age-related macular degeneration and polypoidal choroidal vasculopathy by next-generation sequencing

  2023cites this paper
• Latest Development on Genetics of Common Retinal Diseases

  2023cites this paper
• RISK OF EXUDATION IN EYES WITH NONEXUDATIVE POLYPOIDAL CHOROIDAL VASCULOPATHY

  2023influential citation
• Diagnosing Polypoidal Choroidal Vasculopathy Using Color Fundus Photography, Optical Coherence Tomography, and Optical Coherence Tomography Angiography

  2023cites this paper
• Mechanistic Insight into Age-Related Macular Degeneration (AMD): Anatomy, Epidemiology, Genetics, Pathogenesis, Prevention, Implications, and Treatment Strategies to Pace AMD Management

  2023cites this paper
• Contribution of common and rare variants to Asian neovascular age-related macular degeneration subtypes

  2023cites this paper
• Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan

  2023cites this paper
• Short-Term Safety and Efficacy of Intravitreal Brolucizumab Injections for Neovascular Age-Related Macular Degeneration: A Multicenter Retrospective Real-World Study

  2023cites this paper
• Analysis of ocular fluid in patients with ranibizumab-recalcitrant neovascular age-related macular degeneration who have serum anti-ranibizumab antibodies

  2023cites this paper
• Macular neovascularization and polypoidal choroidal vasculopathy: phenotypic variations, pathogenic mechanisms and implications in management

  2023cites this paper
• Vortex vein engorgement and different shapes of venous drainage systems in polypoid choroidal vasculopathy vs. age‑related macular degeneration on indocyanine green angiography

  2023influential citation
• Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy

  2022cites this paper
• Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria In White Patients With Neovascular Age-Related Macular Degeneration.

  2022cites this paper
• CRISPR/Cas9—A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects

  2022cites this paper
• Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients

  2022cites this paper
• LONGITUDINAL ASSESSMENT OF CHOROIDAL STRUCTURE IN PATIENTS WITH MACULAR NEOVASCULARIZATION

  2022cites this paper
• An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access

  2022influential citation
• Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort

  2022cites this paper
• Differences in clinical characteristics and treatment outcomes of submacular hemorrhage caused by age-related macular degeneration and retinal macroaneurysms: A multicenter survey from the Japan Clinical Retina Study (J-CREST) group

  2022cites this paper
• Peripheral complete blood cell count indices and serum lipid levels in polypoidal choroidal vasculopathy

  2022cites this paper
• Functional Connectivity Hypointensity of Middle Cingulate Gyrus and Thalamus in Age-Related Macular Degeneration Patients: A Resting-State Functional Magnetic Resonance Imaging Study

  2022cites this paper
• RISK OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY

  2022cites this paper
• Pigmentary abnormality without significant drusen as a risk factor for late age-related macular degeneration

  2022cites this paper
• Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence

  2022cites this paper
• POLYPOIDAL CHOROIDAL NEOVASCULARIZATION VERSUS TYPE 1 CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION

  2022cites this paper
• Profile of patients treated with intravitreal anti-vascular endothelial growth factor injections in Bhutan: a 3-year national survey

  2022cites this paper
• Recent Advances in Clinical Applications of Imaging in Retinal Diseases.

  2022cites this paper
• Clinical explainable differential diagnosis of polypoidal choroidal vasculopathy and age-related macular degeneration using deep learning

  2022cites this paper
• Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup

  2022cites this paper
• Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy

  2022cites this paper
• Visual Parameters and Retinal Morphology for Polypoidal Choroidal Vasculopathy Pre- and Post-Intravitreal Ranibizumab with or without Photodynamic Therapy: A Short-Term Prospective Study

  2021cites this paper
• Polypoidal Choroidal Vasculopathy in Caucasians: Morphological Findings from Multimodal Retinal Imaging

  2021cites this paper
• Polypoidal choroidal vasculopathy in a patient with early-onset large colloid drusen

  2021cites this paper
• Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy.

  2021influential citation
• Real-World Outcomes of Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: A Large-Scale Postmarketing Surveillance in Korea

  2021cites this paper
• One year outcomes of eyes with polypoidal choroidal vasculopathy with ≥20/40 visual acuity treated with anti-vascular endothelial growth factor agents

  2021cites this paper
• Real-world outcomes of combined therapy of photodynamic therapy with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy

  2021cites this paper
• Long-term outcomes of polypoidal choroidal vasculopathy in comparison with typical exudative age-related macular degeneration

  2021cites this paper
• Multimodal imaging comparison of polypoidal choroidal vasculopathy between Asian and Caucasian population.

  2021cites this paper
• Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations From the Asia-Pacific Vitreo-retina Society

  2021cites this paper
• Differential Genotypes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A Updated Meta-Analysis

  2021cites this paper
• Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

  2021cites this paper
• PERIPHERAL EXUDATIVE HEMORRHAGIC CHORIORETINOPATHY-A NEW ADDITION TO THE SPECTRUM OF PACHYCHOROID DISEASE?

  2020cites this paper
• Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis

  2020cites this paper
• Learning Two-Stream CNN for Multi-Modal Age-Related Macular Degeneration Categorization

  2020cites this paper
• Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-ICGA Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society (APOIS) PCV Workgroup.

  2020cites this paper
• Polypoidal Choroidal Vasculopathy: Diagnostic and Therapeutic Considerations

  2020cites this paper
• Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age‐related macular degeneration

  2020cites this paper
• Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration

  2020cites this paper
• The polyp regression rate and treatment prognosis of different interventions for polypoidal choroidal vasculopathy: a systematic review and meta-analysis

  2020cites this paper
• Choroidal vascular changes in age-related macular degeneration

  2020cites this paper
• Quantitative analysis of choroidal vasculature in polypoidal choroidal vasculopathy using ultra-widefield indocyanine green angiography

  2020cites this paper
• Fractal analysis of polypoidal choroidal neovascularisation in age-related macular degeneration

  2020cites this paper
• The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification

  2020cites this paper
• Patient-Perceived Benefit of Treatment in Polypoidal Choroidal Vasculopathy: A Pilot Study

  2020cites this paper
• Updates on the Management of Ocular Vasculopathies with VEGF Inhibitor Conbercept

  2020cites this paper
• Association of choroidal thickness with intermediate age-related macular degeneration in a Japanese population.

  2020cites this paper
• Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

  2020cites this paper
• Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

  2020cites this paper
• Characteristics of the inner retinal layer in the fellow eyes of patients with unilateral exudative age-related macular degeneration

  2020cites this paper
• Plasma Levels of Matrix Metalloprotease MMP-9 and Tissue Inhibitor TIMP-1 in Caucasian Patients with Polypoidal Choroidal Vasculopathy

  2020influential citation
• Neovascular AMD

  2020cites this paper
• Angiographic features of polypoidal choroidal vasculopathy using indocyanine green angiography and optical coherence tomography angiography: A comparative study

  2020cites this paper
• Development of an automated system for the detection of genotype in polypoidal choroidal vasculopathy using retinal image phenotype

  2020cites this paper
• Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy

  2020cites this paper
• Comparison of choriocapillary flow density between fellow eyes of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration

  2020cites this paper
• Complement family member CFI polymorphisms and AMD susceptibility from a comprehensive analysis

  2020cites this paper
• DRUSEN SUBTYPES AND CHOROIDAL CHARACTERISTICS IN ASIAN EYES WITH TYPICAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

  2020cites this paper
• Macular Disorders

  2020cites this paper
• The association of polypoidal choroidal vasculopathy clinical phenotypes with previously reported genetic markers

  2020cites this paper
• The comparison of spectral domain optical coherence tomography and indocyanine green angiography in the diagnosis of polypoidal choroidal vasculopathy

  2020cites this paper
• Identification of TIE2 as a susceptibility gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

  2020cites this paper
• Genetic Association of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.

  2020cites this paper
• Analysis of choroidal thickness and vascularity in patients with unilateral polypoidal choroidal vasculopathy

  2020cites this paper
• Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study

  2020cites this paper
• Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy

  2020cites this paper
• Comparison of OCT and OCTA manifestations among untreated PCV, neovascular AMD, and CSC in Chinese population.

  2020cites this paper
• Latest Developments in Polypoidal Choroidal Vasculopathy: Epidemiology, Etiology, Diagnosis, and Treatment

  2020cites this paper
• Evaluation of the association of C5 with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

  2019cites this paper